Lord, Abbett & Co. LLC Sanofi Transaction History

Lord, Abbett & Co. LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$47.07 - $52.35 $8.74 Million - $9.72 Million	-185,757 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$47.89 - $53.12 $1.02 Million - $1.13 Million	-21,246 Reduced 10.26%	185,757 $8.96 Million
Q2 2021 Aug 11, 2021	SELL	$49.36 - $54.25 $519,316 - $570,764	-10,521 Reduced 4.84%	207,003 $10.9 Million
Q1 2021 May 11, 2021	BUY	$45.46 - $50.51 $533,882 - $593,189	11,744 Added 5.71%	217,524 $10.8 Million
Q4 2020 Feb 09, 2021	SELL	$45.3 - $51.62 $650,870 - $741,676	-14,368 Reduced 6.53%	205,780 $10 Million
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $400,756 - $435,590	-8,101 Reduced 3.55%	220,148 $11 Million
Q2 2020 Aug 14, 2020	BUY	$42.91 - $52.5 $9.79 Million - $12 Million	228,249 New	228,249 $11.7 Million

808

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $130B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.